Sperandina Lappa
Sapienza University of Rome
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sperandina Lappa.
Bioorganic & Medicinal Chemistry Letters | 1995
Maria Alessandra Alisi; Mario Brufani; Luigi Filocamo; Gianluca Gostoli; Emanuela Licandro; M.Candida Cesta; Sperandina Lappa; Donata Marchesini; Pier Giuseppe Pagella
Abstract Several new potent acetylcholinesterase inhibitors have been synthesised as potential drugs for the treatment of Alzheimers disease. Heptylphysostigmine (MF201) is a drug analogue of physostigmine under clinical evaluation. In order to obtain new physostigmine analogues, the methylcarbomoyloxy group was substituted with ω-morpholinoalkylcarbamoyloxy moieties of different chain lengths (C2–C12). Potent in vitro inhibition is seen when the chain length is composed of eight to twelve methylene groups. The inhibitory activity of the C10 and C11 is 7-fold greater with respect to heptylphysostigmine.
Tetrahedron Letters | 1992
Maria Alessandra Alisi; Mario Brufani; Luigi Filocamo; Gianluca Gostoli; Stefano Maiorana; Maria Candida Cesta; Enrico Ferrari; Sperandina Lappa; Piergiuseppe Pagella
Abstract the synthesis of phosphatidylinositol (PI) analogues (±)1- O -(1- O -octadecanoyl-2- O -acetyl- rac -3-thioglycerylphosphoryl)- myo -inositol ( 7 ), (±)1- O -(1,2-di- O -octadecyl- rac -3-thioglycerylphosphoryl)- myo -inositol ( 14a ), (±)1- O -(1,2-di- O -octyl- rac -3-thioglycerylphosphoryl)- myo -inositol ( 14b ) and (±)1- O -(1- O -octadecyl-2- O -methyl- rac -3-thioglycerylphosphoryl)- myo -inositol ( 14c ) designed to show a novel mode of PI-phospholipase C (PI-PLC) inhibition, is described.
Tetrahedron Letters | 1992
Maria Alessandra Alisi; Mario Brufani; Luigi Filocamo; Gianluca Gostoli; Sperandina Lappa; Stefano Maiorana; Maria Candida Cesta; Enrico Ferrari; Pier Giuseppe Pagella
Abstract the synthesis of analogues of phosphatidylinositol (PI), designed to show a novel mode of PI-phospholipase C (PI-PLC) inhibition, is described.
Carbohydrate Research | 1992
Mario Brufani; Maria Candida Cesta; Lucia Donnarumma; Luigi Filocamo; Gianluca Gostoli; Sperandina Lappa; Enrico Ferrari; Pier Giuseppe Pagella
The syntheses are described of the 1-O-carbamoyl (11), 1-O-carbamoyl-2-O-stearoyl (10), 1-O-(acetylcarbamoyl)-2-O-stearoyl (12), 1-O-(heptylcarbamoyl) (13), 2-O-(heptylcarbamoyl) (14) 1,2-di-O-(heptylcarbamoyl) (15), and 1-O-(octadecylcarbamoyl) (16) derivatives of myo-inositol. None of these compounds had significant activity against phospholipase C.
Bioorganic & Medicinal Chemistry Letters | 1993
Maria Alessandra Alisi; Mario Brufani; Luigi Filocamo; Gianluca Gostoli; Luciano Cellai; M.Adeilade Iannelli; Gennaro Melino; Maria Candida Cesta; Sperandina Lappa
Abstract the synthesis of the phosphatidylinositol (PI) analogue (±)-octadecylphosphodithionyl-1- myo -inositol is described. The cytotoxic activity on K562 erythroleukaemic cells and the effect on the activity of PI specific phospholipase C (PI-PLC) from human platelets are reported.
Synthetic Communications | 1991
Maria Candida Cesta; Luigi Filocamo; Sperandina Lappa; Carlo Meroni
Abstract The synthesis of (±)10H-phenothiazine-10-propanoyl-1′-myo-inositol was accomplished in order to test it as inhibitor of phosphatidylinositol specfic phospholipase C (PI-PLC).
Archive | 1992
Mario Brufani; Maria Candida Cesta; Enrico Ferrari; Luigi Filocamo; Sperandina Lappa; Stefano Maiorana; Pier Giuseppe Pagella
Archive | 1993
Maria Alessandra Alisi; Mario Brufani; Maria Candida Cesta; Luigi Filocamo; Gianluca Gostoli; Sperandina Lappa; Pier Giuseppe Pagella; Enrico Ferrari; Stefano Maiorana; Donata Marchesini
Farmaco | 1992
Mario Brufani; Cesta Mc; Luigi Filocamo; Sperandina Lappa; Marta M; Pomponi M; Meroni C; Pagella Pg
Archive | 1994
Maria Alessandra Alisi; Mario Brufani; Maria Candida Cesta; Luigi Eieocamo; Gianluca Gostoli; Sperandina Lappa; Pier Giuseppe Pagella; Enrico Ferrari; Stefano Maiorana; Donata Marchesini